Anvisa manager criticizes, but recommends approval of CoronaVac

[ad_1] The general director of Medicines and Biological Products of Anvisa (National Surveillance Agency Sanitary), Gustavo Mendes, said this morning that the CoronaVac vaccine, produced by the Butantan Institute with the Chinese laboratory Sinovac, had data from immunogenicity considered inappropriate, but, in view of the Brazilian need, recommended immunizer approval. …

Read More »